Medical Communications

Showing 15 posts of 6408 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

R&D tax credits: A novel approach to supply chain funding

September 1, 2017 Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …
astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017 Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

NHS pumps £100m into GP recruitment as numbers plummet

September 1, 2017 Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical

The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …
genentechlr

FDA approves treatment to counter CAR-T side-effects

August 31, 2017 Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …

Abbott issues patch for vulnerable heart devices

August 31, 2017 Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …
governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017 Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

Novartis names new Chief Digital Officer

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
adults-1853851_960_720

Thyroid disorders: An illness underestimated

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

August 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …
goggles-1683644_960_720

The pharmacovigilance market dynamic

August 25, 2017 Medical Communications biotech, drugs, pharma, pharmaceutical, pharmacoviglance

Pharmacovigilance is a science of understanding drug safety through identification, assessment, and prevention of adverse drug reactions (ADRs). It is …
The Gateway to Local Adoption Series

Latest content